Skip to main content

4 Result(s)

within Daniel Reimer Remove this filter Medicine & Public Health Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    PARP inhibitors in the treatment of ovarian cancer

    The recent exciting findings on the use of poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitor (PARPi) maintenance therapy in the first-line and later lines of treatment in ovarian cancer are illustr...

    Alain G. Zeimet, Verena Wieser… in memo - Magazine of European Medical Oncolo… (2020)

    Download PDF (208 KB) View Article

  2. Article

    Open Access

    Evaluation of Vav3.1 as prognostic marker in endometrial cancer

    Vav3 is a guanine nucleotide exchange factor that regulates the activity of Rho/Rac family GTPases. In a study on ovarian cancer, we recently demonstrated pronounced prognostic and predictive value of Vav3.1, ...

    Maximilian Boesch, Sieghart Sopper… in Journal of Cancer Research and Clinical On… (2018)

    Download PDF (2198 KB) View Article

  3. No Access

    Article

    Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer

    The main objective of the present investigation was to study the urinary neopterin excretion in the context of the activation of the adaptive cellular immune system at the tumor site. For this purpose, we comp...

    Alain G. Zeimet, Daniel Reimer, Lukas Schwentner… in Cancer Immunology, Immunotherapy (2010)

  4. No Access

    Article

    Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer

    This study analyzes the relationship between coxsackie-adenovirus receptor (CAR) expression (transmembrane and soluble isoforms) and hormone sensitivity in 95 breast cancers. Furthermore, prognostic significan...

    Doris Auer, Daniel Reimer, Verena Porto… in Breast Cancer Research and Treatment (2009)